Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial Fibrillation

about

Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial Fibrillation

Item

http://www.wikidata.org/entity/Q37115151

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy And Safety of Dabigat ...... Therapy In Atrial Fibrillation

@en

Efficacy And Safety of Dabigat ...... herapy In Atrial Fibrillation.

@nl

type

Item

label

Efficacy And Safety of Dabigat ...... Therapy In Atrial Fibrillation

@en

Efficacy And Safety of Dabigat ...... herapy In Atrial Fibrillation.

@nl

prefLabel

Efficacy And Safety of Dabigat ...... Therapy In Atrial Fibrillation

@en

Efficacy And Safety of Dabigat ...... herapy In Atrial Fibrillation.

@nl

P1476

Efficacy And Safety of Dabigat ...... Therapy In Atrial Fibrillation

@en

P2093

Osmar Antonio Centurión Md PhD Facc

http://www.w3.org/2001/XMLSchema#string

P2860

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Dabigatran versus warfarin in patients with atrial fibrillation

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Validation of Clinical Classification Schemes for Predicting Stroke

P304

1001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4022/JAFIB.1001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27957046

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

4956134

http://www.w3.org/2001/XMLSchema#string